The prevalence of adult ADHD is higher than those reported for general population in patients with iron deficiency anemia. Early diagnose and treatment of adult ADHD may positively contribute to the patients with iron deficiency anemia.
Objective: To determine changes caused by the effect of the COVID-19 pandemic by examining the children admitted to our hospital because of poisoning during the pandemic and comparing these with data from a study conducted in the pre-pandemic period. Materials and Methods: A retrospective examination was made of children who were admitted to our pediatric emergency department with poisoning between March 2020 and March 2022. Results: Of the 82 (0.7%) patients admitted to the emergency department, 42 (51.2%) were girls, the mean age was 6.43 ± 5.62 years, and the majority of children (59.8%) were under 5 years of age. The poisonings were determined to be accidental in 85.4% of cases, 13.4% were suicide attempts, and 1.2% were iatrogenic. Poisonings occurred most frequently (97.6%) at home and most frequently (85.4%) by digestive tract. The most common causative agent (68%) was non-pharmacological agents. Caustic-corrosive substances were determined in 39% of cases, medical drugs in 32%, toxic gases in 11%, alcohol (hand sanitizers) in 8.5%, insecticide-pesticide in 6.1%, food in 1.2%, and animal bites in 1.2%. Compared to the study conducted in our hospital in 2013-2014, the difference in terms of factors causing poisoning was statistically significant ( P < .001). Of the current study cases, 14 (17.1%) were followed up in the intensive care unit, and no mortality developed. Conclusions: The period of the COVID-19 pandemic was seen to cause an increase in poisoning rates with caustic-corrosive substances, alcohol (hand disinfectants), and toxic gases. Families should be made aware of this issue and take special precautions.
ÖZETAmaç: Baş ağrısı, genel polikliniklere en sık başvuru nedenlerdendir. Son yıllarda metabolik sendrom, obezite ve primer baş ağrıları arasındaki ilişki dikkati çekmekte-dir. Amacımız hiperlipidemi ve baş ağrısı arasındaki ilişkiyi araştırmaktadır. Yöntemler: Lipid düzeyleri ölçülerek uluslararası kolesterol eğitim programı erişkin tedavi paneli III (NCEP ATP III) kriterlerine göre hiperlipidemi tanısı alan 92 kişi ve sağlıklı 100 kişi çalışmaya dâhil edildi. Tüm kişilerde baş ağrısının varlığı, süresi, sıklığı, atak süresi ve ağrının şiddeti araştırıldı. Bulgular: Katılımcıların yaş ortalamaları 37±13,8 yıldı. Yüz altısı (%55,2) kadın, 86'sı (%44,8) erkekti. İki grup yaş ve cinsiyet olarak benzerdi. Hiperlipidemi grubunda, 30 (%32,6) kontrol grubunda 16 (%16,0) kişide baş ağrısı tespit edildi. Hiperlipidemi grubunda baş ağrısı varlığı istatistiksel olarak anlamlı şekilde yüksekti (p=0.04). Baş ağrısı tipleri arasında anlamlı fark yoktu (p=0,9). Hiperlipidemili hastalarda atak şiddeti ve atak süresi kontrole göre daha yüksek bulundu (p=0,003, p=0,04). Sonuç: Çalışmamız hiperlipidemili hastalarda baş ağrısının sık olabileceğini göster-mektedir. Bu nedenle klinisyenler hiperlipidemili hastalarda baş ağrısının farkında olmalıdır.Anahtar kelimeler: Baş ağrısı, hiperlipidemi, migren ABSTRACT Objective: Headache is the most common complaint of the patients, who applied to general outpatient clinics. In recent years, association between metabolic syndrome, obesity, and primary headaches has attracted much attention. Our aim was to investigate the association between headache and hyperlipidemia. Methods: Ninety-two participants with hyperlipidemia and 100 healthy controls were enrolled in this study. The diagnosis of hyperlipidemia was made according to National Cholesterol Education Program Adult Treatment Panel III criteria. We investigated the presence, duration, frequency, severity of headache, the duration of headache attack. Results: Mean age of the participants was 37±13.8 years. Of all participiants, 106 (55.2%) were females, 86 (44.8%) were males. Two groups were similar in terms of gender and age. In the hyperlipidemia group, 30 (32.6%) patients had headache, and in the control group 16 (16.0%) cases had headache. This difference was statistically significant (p=0.04). There was no statistically significant difference between the groups according to the type of headache (p=0.9). The patients with hyperlipidemia had significantly higher VAS and prolonged headache attacks compared to the controls (p=0.003, p=0.04). Conclusions: Our study suggests that headache may be frequent in hyperlipidemia patients. Therefore, clinicans should be aware of headache in hyperlipidemia patients. Araşt. Hast. Dergisi 2015; 25(3):186-190 doi:10.5222/terh.2015.186 Gİrİş Baş ağrısı, nöroloji ve genel polikliniklere başvu-ran hastaların en sık başvuru nedenlerinden biridir. Ülkemizde baş ağrısı nedeni ile doktora başvuru oranı %38,9 olup, bu oran kadınlarda %46,1, erkek-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.